Jordi Díaz‐Manera

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations

Catherine L. Bladen, David Salgado, Soledad Monges et al. · Human Mutation · 2015 · 744 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg

Luís Querol, Gisela Nogales‐Gadea, Ricardo Rojas‐García et al. · Neurology · 2014 · 367 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy

Luís Querol, Gisela Nogales‐Gadea, Ricard Rojas‐García et al. · Annals of Neurology · 2012 · 349 citations

Medicine, Neurology, Neuroscience +17

Long-lasting treatment effect of rituximab in MuSK myasthenia

Jordi Díaz‐Manera, Eugenia Martínez‐Hernández, Luís Querol et al. · Neurology · 2012 · 342 citations

Life Sciences, Immunology, Pharmacotherapy +16